Using a Tumor’s Composition to Activate an Immune Response
Modulating Cancer Immunity
Learn how immunotherapies harness a person’s immune system to fight cancer
Learn more about Aduro’s clinical programs
Download the 2017 Annual Report
December 03, 2018 Aduro Biotech and Dana-Farber Cancer Institute Present Preclinical Data Supporting Anti-APRIL Antibody BION-1301 for the Treatment of Multiple Myeloma at the 60th American Society of Hematology Annual Meeting and Exposition
Are you interested in working for a company where interactions are authentic, commitment is high and people excel together?